digiDEM Bavaria Statement on Donanemab

The German Federal Joint Committee's (G-BA) decision of April 16, 2026, to classify the additional benefit of Donanemab as „not substantiated“ does not surprise the digiDEM project management. The G-BA had already reached this conclusion for Lecanemab in February 2026 of this year. Now it appears that the second drug with a similar mechanism of action also cannot...

When digital services can help with Alzheimer's

Digital technologies are playing an increasing role in the care of people with Alzheimer's disease. Telemedical consultations, apps for daily routine structuring, or digital training programs are intended to relieve caregivers and enable those affected to have more independence. In practice, however, digital offerings present individual hurdles that make their use in everyday life more difficult. Researchers…

Communication with dementia: how helpful are tips from the internet?

Good communication is an essential building block for the quality of life of people with dementia and their relatives and caregivers. Since scientific literature is often difficult to access, many people seeking advice research practical tips for everyday life on the internet. But how well-founded are these online guidelines really? A recent study from Great Britain examined 39...

When communication becomes an obstacle: Focus on support systems for caregiving relatives

Communication difficulties are among the most burdensome situations in dementia. As conversations become more difficult and mutual understanding declines, those affected often experience increased frustration and social isolation. But it's not just those with the illness who suffer: a current review highlights that communication barriers are a cause of stress and burnout for caregivers. Support...

Communication as the key: paths to personalized dementia care

In modern dementia care, personalized care is a crucial factor for quality of life. This brings one question to the forefront: How can healthcare professionals recognize and meet the individual needs of those affected as verbal communication becomes more difficult? A current systematic review from London provides answers to this. The research team analyzed 33 studies…

Diagnosis, Prognosis, Prevention: How Memory Clinics Communicate with Patients

The medical care of people with Alzheimer's dementia (AD) is undergoing a fundamental paradigm shift. As deposits in the brain associated with the development of the disease can be detected decades before the first symptoms, early stages of the disease and personalized medicine are increasingly coming into focus. This change presents professionals, particularly in...

digiDEM Bavaria Statement on Lecanemab

The decision by the Joint Federal Committee (G-BA) of February 19, 2026, to classify the additional benefit of Lecanemab as ‚not proven‘ confirms the skepticism of the digiDEM project management regarding the clinical relevance of this therapy. While the only study available so far on Lecanemab shows a statistically significant difference between the drug and a placebo at the end of the study...